11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2017
-
Mark
Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks
(
- Contribution to journal › Article
-
Mark
Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria
(
- Contribution to journal › Article
- 2016
-
Mark
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2012
-
Mark
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
(
- Contribution to journal › Article
- 2008
-
Mark
The costs of treating glaucoma with combinations of topical drugs in Spain
(
- Contribution to journal › Article
-
Mark
Models from experiments: combinatorial drug perturbations of cancer cells
(
- Contribution to journal › Article
- 2007
-
Mark
Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium
(
- Contribution to journal › Article
- 2003
-
Mark
Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: A Nordic study
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »